Overview of Тенорик

Quick Facts

Property	Description
Active ingredients	Atenolol, Chlorthalidone
Form	Film-coated tablets
Pharmacological class	Antihypertensive Agent (Beta-blocker + Diuretic)
Common use	Management of high blood pressure (Hypertension)
Origin	Synthetic

Тенорик: Fixed-Dose Combination and Pharmacological Class

Тенорик is an antihypertensive agent classified as a fixed-dose combination (FDC) drug, incorporating two distinct, synthetic active substances within a single tablet. As a prescription-only medication, its primary function is the long-term, comprehensive management of essential hypertension (high blood pressure). The strategy of combining a beta-blocker with a diuretic in a single FDC product is widely supported by clinical recognition for improving therapeutic adherence compared to regimens requiring multiple pills. This consolidated approach offers a simplified foundation for treating adults with uncontrolled elevated blood pressure.

Active Ingredients and Dual Mechanism (Atenolol and Chlorthalidone)

The composition of Тенорик is defined by its dual action, provided by Atenolol and Chlorthalidone. Atenolol is a cardioselective beta-blocker that mitigates stress signals on the heart, reducing the rate and force of contractions. Chlorthalidone is a potent thiazide-like diuretic, chemically related to the sulfonamides, which reduces fluid volume by promoting the kidney's excretion of salt and water. This pairing is clinically recognized for achieving sustained pressure reduction. Popular brands containing the same combination include Tenoretic and Tenorid, confirming the established use of this specific two-component formulation across various markets.

Dosage Form and Route of Administration

Тенорик is supplied exclusively as film-coated tablets, the convenient dosage form designed for oral administration. The tablet design ensures the simultaneous delivery of both active ingredients into the systemic circulation. This formulation is distinctive due to the inherent properties of its components; for example, Atenolol has low lipophilicity, while Chlorthalidone is notable for its longer duration of action compared to many other diuretics. These features contribute to the profile of this particular fixed-dose preparation.

Regulatory References

DailyMed Label for Atenolol/Chlorthalidone

What side effects are possible with Тенорик?

Official Safety Profile and Adverse Reactions

The safety profile for the fixed-dose combination of Atenolol and Chlorthalidone (Тенорик) is organized in regulatory documents by the frequency of documented adverse reactions and the physiological system affected, consistent with regulatory standards.

Adverse effects are formally classified based on observed frequency, with Common reactions (affecting up to 1 in 10 people) including fatigue, cold extremities, bradycardia (slow heart rate), gastrointestinal disturbances, headache, and dizziness. Reactions such as mood alterations and sleep disturbances are classified as Uncommon, while Rare reactions (affecting up to 1 in 1,000 people) include impotence, alopecia, and dry eyes. The label notes the Very Rare occurrence of serious reactions such as Toxic epidermal necrolysis (TEN).

Reactions are grouped by System-Organ Classes (SOC), including Cardiac disorders (e.g., bradycardia), Nervous system disorders (e.g., dizziness), and Metabolism and nutrition disorders (e.g., hypokalemia and other electrolyte imbalances).

Safety Constraints and Considerations

The regulatory profile identifies several absolute constraints (contraindications), including symptomatic bradycardia, cardiogenic shock, overt heart failure, and severe renal or hepatic failure. The label also notes specific safety considerations for patient populations, such as the potential for masking signs of hypoglycemia in diabetic patients or the risk of exacerbating existing heart failure. Monitoring for electrolyte changes, such as hypokalemia due to the diuretic component, is noted within the regulatory safety documentation.

Overdose and Emergency Response

Overdose involving the combined agents in Тенорик (Atenolol/Chlorthalidone) is documented by regulatory authorities to cause severe, potentially life-threatening effects. Patients must seek immediate medical attention upon suspicion of overexposure, as the required interventions are procedural and demand hospital facilities.

Overdose Domain	Documented Manifestations
Cardiovascular & CNS	Bradycardia (slow heart rate), Hypotension, Overt Cardiac Failure, Lethargy, Extreme Weakness.
Respiratory & Metabolic	Bronchospasm (wheezing), Hypoglycemia (low blood sugar), and Electrolyte Imbalance which may lead to Hepatic Coma in vulnerable patients.

Emergency Interventions (Regulator-Described)	Status
Antidote	No specific antidote is officially documented.
Supportive Measures	Management involves Symptomatic and Supportive Treatment. Procedures listed for removal of unabsorbed drug include Gastric Lavage and Activated Charcoal. Hemodialysis is documented for removing the Atenolol component.

The regulatory profile strictly defines the overdose as an acute emergency with a focus on stabilizing critical vital signs, particularly reversing profound hypotension and cardiac depression. These procedural requirements underscore the mandated instruction to seek urgent medical help immediately to access necessary monitoring and specialized supportive care.

Therapeutic Uses of Тенорик

What Тенорик Treats: Main Uses and Benefits

Тенорик is commonly used for the long-term management of essential hypertension (chronic high blood pressure) in adults. It is considered relevant to lower blood pressure and addresses the systemic risks associated with chronic high blood pressure. This medication may be part of symptomatic management when the patient's condition requires a combined therapeutic approach to maintain stable control.

The medication is applied to address sustained pressure elevation and chronic vascular stress. Its therapeutic use is relevant for conditions characterized by periods of heightened systemic burden, primarily essential hypertension. As a fixed-dose combination, it helps address the physiological aspects of this condition, assisting with stable blood pressure control and contributing to long-term systemic stability.

“This approach supports the patient's daily treatment schedule, which contributes to improved treatment adherence.”

This formulation is applicable in clinical settings requiring dual therapy for uncontrolled chronic hypertension. It supports patients needing sustained relief by managing symptoms related to systemic imbalance and heightened physiological activity.

Quick Fact: Supportive Management for Vascular Stress

Context	Primary Therapeutic Focus
Condition	Essential hypertension (chronic high blood pressure)
Symptom Domain	Sustained pressure elevation
Primary Therapeutic Focus	Assisting with managing blood pressure within established target ranges

Eligibility and Restrictions for Use

The eligibility for Тенорик (atenolol/chlorthalidone) is strictly defined by official regulatory labeling, which outlines specific patient populations who must not use the medicine.

Contraindicated Populations

The medicine is absolutely forbidden for patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, overt cardiac failure, and anuria (inability to produce urine). It is also contraindicated for patients with known hypersensitivity to either component or to any sulfonamide-derived drugs.

Eligibility Restrictions

Use is not recommended during pregnancy (especially the second and third trimesters) due to the risk of fetal harm, and generally not advised during breastfeeding. Dosage adjustment and caution are required for patients with impaired renal function (Creatinine Clearance CrCl < 35 mL/min) or impaired hepatic function. For pediatric patients, safety and effectiveness have not been established by regulatory authorities, meaning use is not approved. Caution is advised when prescribing to older adults due to the increased frequency of reduced organ function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Тенорик's dual composition (Atenolol and Chlorthalidone) results in documented interaction patterns based on regulatory labeling. These interactions primarily fall into two domains: additive pharmacodynamic effects and pharmacokinetic modifications.

Pharmacodynamic Interactions and Risks

Co-administration with other antihypertensive agents or Digitalis glycosides may result in additive effects on blood pressure and A-V conduction, leading to an increased risk of marked bradycardia or hypotension.
Verapamil and Diltiazem should not be administered intravenously within 48 hours of discontinuing the beta-blocker component due to the risk of severe cardiac depression, as defined by the SmPC.
The hypotensive effect may be diminished by Nonsteroidal Anti-inflammatory Drugs (NSAIDs) due to pharmacodynamic antagonism.
In patients with diabetes, Atenolol can mask the early warning symptoms of hypoglycemia (e.g., tachycardia).

Pharmacokinetic and Timing Constraints

The diuretic component may reduce the renal clearance of Lithium, leading to increased serum concentrations and a high risk of toxicity.
Substances that inhibit absorption, such as Aluminum Hydroxide and Multivitamin with Minerals, require separation of administration by at least 2 hours to maintain effective Atenolol exposure.
Specific procedural constraints apply to Clonidine; the beta-blocker component must be withdrawn several days before the gradual withdrawal of Clonidine.
Alcohol co-administration is noted for its potential for additive hypotensive effects.

Mechanism of Action

Тенорик is a fixed-dose combination containing the beta1-selective adrenergic receptor antagonist, atenolol, and the thiazide-like diuretic, chlorthalidone.

Atenolol acts primarily as a competitive antagonist at beta1-adrenergic receptors, which are localized predominantly in the heart. This interaction blocks the stimulatory effects of endogenous catecholamines (e.g., norepinephrine) on the sinoatrial and atrioventricular nodes, resulting in a negative chronotropic (decreased heart rate) and negative inotropic (decreased myocardial contractility) effect. Atenolol also inhibits the release of renin from the juxtaglomerular cells in the kidney, modulating the renin-angiotensin-aldosterone system.

Chlorthalidone exerts its mechanism by acting as an inhibitor of the Na^+/ Cl^- cotransporter in the distal convoluted tubule of the nephron. This blockade reduces the reabsorption of sodium and chloride ions, consequently increasing the osmotic load within the tubule and promoting a diuretic effect. The resulting increased fluid excretion leads to a reduction in plasma and extracellular fluid volume. These distinct molecular and cellular actions collectively modulate systemic hemodynamics, culminating in a reduction of cardiac output and total peripheral resistance.

Dosage and Administration Information

How to Use Тенорик

Тенорик (Atenolol and Chlorthalidone) is administered orally as a film-coated tablet and is used within a once-daily schedule for the long-term management of high blood pressure. The fixed-dose combination is typically not indicated for initial therapy but serves as a therapeutic substitution for patients whose doses of the individual components have already been established and match the combination strengths. The two available labeled strengths are 50 mg Atenolol / 25 mg Chlorthalidone and 100 mg Atenolol / 25 mg Chlorthalidone.

Standard Dosing and Administration

Treatment is usually initiated with one 50 mg/25 mg tablet taken once a day. If a patient does not achieve an optimal response to the initial dose, the dosage may be advanced to one 100 mg/25 mg tablet once daily. The dosage must always be individualized to the patient's specific needs.

Population-Specific Use

Dosing requires careful adjustment in specific populations, based primarily on the excretion profile of the Atenolol component:

Renal Impairment: For patients with Creatinine Clearance (CrCl) <35 mL/min/1.73 m^2, the maximum daily dose of Atenolol must be reduced. For severe impairment ( CrCl <15 mL/min/1.73 m^2), the maximum dose is equivalent to 50 mg Atenolol every other day. The fixed combination is generally not recommended for those with severe renal impairment due to reduced diuretic efficacy.
Older Adults (Geriatric): Dosing must be selected cautiously, often starting at the lower end of the dosing range, reflecting the greater frequency of decreased organ function in this group.
Pediatric Use: The safety and effectiveness of the combination have not been established in children under 18 years of age, and its use is not recommended.

Discontinuation Protocol

If the therapy must be discontinued, the treatment should be withdrawn gradually over a period of about two weeks. This controlled, time-dependent reduction is a mandated procedure within the official use protocol.

Recent Clinical Evidence

Research evidence / Overview of studies for Тенорик

Evidence for Use in Essential Hypertension (High Blood Pressure)

Research examining the fixed-dose combination of Atenolol and Chlorthalidone was studied for its application in contexts involving chronic high blood pressure. The primary evidence was derived from Randomized Controlled Trials (RCTs) and systematic reviews that research examined how blood pressure measurements changed in adults with mild-to-moderate hypertension. These studies focused on outcomes monitoring physiological strain or stress, specifically changes in mean systolic and diastolic blood pressure over short defined time intervals.

Findings describe patterns observed in the studies where the combination was observed in adult populations presenting with sustained pressure elevation. Trial reports indicated measurements related to achieving and maintaining lower blood pressure measurements. Research highlights changes measured during the study period, focusing on how consistently lower blood pressure measurements were observed in association with the use of the combination.

Studies Comparing the Combination Pill to Separate Components

Research was evaluated in settings comparing the combination tablet to scenarios where patients took the same two ingredients as separate pills. These observational cohorts and studies explored patient-reported outcomes describing perceived discomfort related to managing complex daily medication schedules. The focus of these trials was on measures related to daily functioning, specifically monitoring patient treatment adherence and persistence. Findings indicate that the single-pill regimen was associated with patterns of adherence observed in the studied populations compared to regimens requiring multiple pills.

Gaps in the Research: What Remains Uncertain

Direct evidence for the long-term impact on major cardiovascular events, such as strokes or heart attacks, is limited for this specific fixed-dose combination. Long-term effects are not fully established directly for the specific combination. Data for certain groups remain insufficient, particularly for pediatric populations, where limited information is available from dedicated trials. Comparative evidence is lacking for direct, head-to-head comparative research of this fixed combination against newer fixed-dose regimens concerning long-term cardiovascular outcomes.

Key Studies & References

Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study (Rana et al., 2018)

Frequently Asked Questions (FAQ)

Common questions about Тенорик (FAQ)

Q: How long does it typically take to start feeling the effects of Тенорик?

According to official product information, the Atenolol component (the beta-blocker) is described as starting to affect heart rate within approximately one hour after a single dose. The maximum effect is typically observed within 2 to 4 hours. The overall blood pressure-lowering effect of the combination is designed to persist for at least 24 hours to support its once-daily use.

Q: Is it common to feel tired when taking Тенорик?

Yes, fatigue and generalized tiredness are among the adverse reactions that are commonly reported in regulatory safety profiles. Common reactions are defined as those that occur in up to 1 in 10 people. If feelings of tiredness are bothersome, it is appropriate to discuss this with a healthcare professional.

Q: What should be done if a dose of Тенорик is missed?

Official patient guidance describes taking the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is typically skipped, and the regular schedule is resumed. Regulatory guidance typically advises against taking a double or extra dose to compensate for a missed one.

Q: How quickly does the effect of Тенорик wear off after stopping?

The elimination half-life of the Atenolol component (the time it takes for half the drug to be eliminated from the body) is approximately 6 to 7 hours. However, regulatory instructions indicate that therapy withdrawal should be done gradually over a period of about two weeks under professional supervision.

Q: Does the diuretic component of Тенорик cause frequent urination?

The mechanism of the Chlorthalidone component is to act as a diuretic, meaning it works by increasing the kidney's excretion of salt and water. While the official adverse reaction list does not specifically categorize frequent urination as a common side effect, the known pharmacological action is to move extra fluid into the urine.

Q: Can Тенорик be used for conditions other than high blood pressure?

The fixed-dose combination product, Тенорик, is specifically indicated in official regulatory documents only for the treatment of hypertension, which is high blood pressure.

Q: Does Тенорик affect heart rate?

Yes, the Atenolol component is a beta-blocker, which is known to decrease the heart rate and force of contraction. Bradycardia, which is a slow heart rate, is listed as a commonly reported adverse reaction in the regulatory safety profile.

Q: Is it necessary to take Тенорик long-term?

Тенорик is an antihypertensive agent intended for the long-term management of high blood pressure. Since high blood pressure often requires ongoing control, for many patients, continuous use of blood pressure medication may be indicated.

Q: Does Тенорик cause weight gain?

Weight gain is not commonly listed as a direct side effect in the regulatory profile. However, official warnings advise monitoring for unexplained or rapid weight gain and swelling, as such observations should be brought to the attention of a healthcare professional promptly, as they can be signs of worsening heart failure.

Q: Can Тенорик affect sleep patterns?

Official safety profiles list sleep disturbances and vivid dreams or nightmares as possible adverse reactions. Sleep disturbances are formally classified as uncommon reactions, meaning they affect up to 1 in 100 people.

Q: What is the evidence regarding Тенорик's long-term use?

Long-term studies on the Atenolol component suggest that its ability to lower blood pressure has not been observed to diminish with prolonged use. The fixed combination is intended to be used for the sustained, long-term management of essential hypertension.

Q: Is Тенорик ever used to help prevent migraines?

The fixed-dose combination drug Тенорик is specifically indicated in regulatory documents only for the treatment of hypertension (high blood pressure).

Q: Is there a generic version of Тенорик available?

Yes, regulatory records confirm that approved generic equivalents containing the same two active ingredients, Atenolol and Chlorthalidone, are available in various international markets.

Q: Is Тенорик considered a first-line treatment for hypertension?

Official regulatory text states that this fixed-dose combination product is not indicated for the initial therapy of hypertension. It is generally described as a therapeutic substitution once the patient’s appropriate doses of the individual components have already been established.

Q: What kind of monitoring is typically involved when taking Тенорик?

The regulatory label notes that medical tests may be required and blood pressure should be checked often. Specific monitoring for changes in the body’s electrolyte levels, such as potassium, and special monitoring for patients with diabetes are also noted in official documents.

Q: Can Тенорик affect mood or cause depression?

Official safety profiles list mood alterations as an uncommon adverse reaction, affecting up to 1 in 100 people. Depression is also noted in the list of possible side effects that have been reported.

Q: What does official guidance say about driving while taking Тенорик?

The official product information indicates that the medicine may cause side effects such as dizziness or fatigue, particularly when treatment begins or the dose is changed. Individuals should be aware of their response to the medication before driving or operating machinery.

Q: Does Тенорик have an approved use for treating chest pain (angina)?

The fixed-dose combination drug Тенорик (Atenolol and Chlorthalidone) is specifically indicated in regulatory documents only for the treatment of hypertension (high blood pressure).

How should Тенорик be stored and disposed of?

How to Store and Dispose of Tenoretic

Tenoretic (atenolol and chlorthalidone) tablets require specific storage and handling conditions as defined in regulatory labeling to maintain product stability and ensure safety.

Official Storage Requirements

Temperature and Protection: The tablets must be stored at Controlled Room Temperature, which is between 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. The product must be protected from both light and moisture. The container must be kept tightly closed and be light-resistant.

Child Safety: The medicine must be kept out of the sight and reach of children and pets.

Official Disposal Instructions

Disposal should preferably be managed through a drug take-back program. If this is unavailable, unused or expired tablets must be removed from the container, mixed with an unappealing substance (like dirt or coffee grounds), and placed into a sealed bag for disposal in household trash. The tablets should not be flushed down the toilet or sink.

Тенорик